MADRID, June 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported data highlighting ...
85% of enterprises want to become agentic within three years — yet 76% admit their operations can’t support it. According to the Celonis 2026 Process Optimization Report, based on a survey of more ...
Biotech Fluidics has expanded its range of DEGASi® PREP+ degassers. Driven by demand for process optimized systems, Biotech Fluidics now offers three DEGASi® PREP+ degassers – standard, large, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results